Jfs Wealth Advisors, LLC Cytokinetics Inc Transaction History
Jfs Wealth Advisors, LLC
- $1.49 Billion
- Q3 2024
A detailed history of Jfs Wealth Advisors, LLC transactions in Cytokinetics Inc stock. As of the latest transaction made, Jfs Wealth Advisors, LLC holds 42 shares of CYTK stock, worth $1,899. This represents 0.0% of its overall portfolio holdings.
Number of Shares
42
Previous 25
68.0%
Holding current value
$1,899
Previous $1,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding CYTK
# of Institutions
408Shares Held
125MCall Options Held
4.6MPut Options Held
2.43M-
Black Rock Inc. New York, NY14.7MShares$664 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$532 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD9.69MShares$438 Million0.31% of portfolio
-
Wellington Management Group LLP Boston, MA7.77MShares$352 Million0.07% of portfolio
-
State Street Corp Boston, MA6.46MShares$292 Million0.01% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $4.26B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...